Biologic National Registry

Biomarkers in Chronic Arthritis

NCT02909998 ·Status: COMPLETED

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis

NCT05046431 ·Status: COMPLETED ·Phase: PHASE3

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

NCT01875991 ·Status: COMPLETED ·Phase: PHASE4

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects

NCT01011959 ·Status: COMPLETED ·Phase: PHASE1

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

NCT04507763 ·Status: COMPLETED

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

NCT01895309 ·Status: COMPLETED ·Phase: PHASE3

Rheumatology Biorepository

NCT04899895 ·Status: ENROLLING_BY_INVITATION

Brigham and Women's Rheumatoid Arthritis Sequential Study

NCT01793103 ·Status: ACTIVE_NOT_RECRUITING

Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs

NCT04139954 ·Status: UNKNOWN

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

NCT01328522 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

NCT01901185 ·Status: COMPLETED ·Phase: PHASE3

European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study

NCT01286545 ·Status: UNKNOWN

Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis

NCT03599986 ·Status: COMPLETED

A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs

NCT03131661 ·Status: COMPLETED

A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis

NCT06596772 ·Status: RECRUITING ·Phase: PHASE3

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

NCT01211678 ·Status: COMPLETED

Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis

NCT04117165 ·Status: WITHDRAWN ·Phase: NA

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

NCT02742337 ·Status: UNKNOWN

Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?

NCT02164214 ·Status: COMPLETED ·Phase: PHASE3

REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations

NCT00121056 ·Status: COMPLETED

Enbrel Liquid Immunogenicity Protocol

NCT00249041 ·Status: COMPLETED ·Phase: PHASE3